InsidersTradesSigma
Genscript Biotech Corporation: insider trades · Hong Kong · HKEX
HKEX:genscript-biotech-corporationHK·HKEXMcap 29.3Bn€Healthcare
Discover the full directors' dealings record of Genscript Biotech Corporation, a listed equity based in Hong Kong. Shares trade on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Genscript Biotech Corporation has published 1 insider filings. Market capitalisation: €29.3bn. The latest transaction was filed on 10 April 2026 — Sale. Among the most active insiders: Shao Weihui. The full history is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€21,765
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
13.43 €
Analyst consensus
7 analysts15.49 €Target 17.67 €(+32%)21.01 €
Income statement
Revenue959.5 M€
Gross profit553.2 M€58% margin
Net income−532.8 M€-55.5% margin
Valuation
PER (forward)216.6x
P/Book0.9x
Beta0.96
Balance sheet & cash
Market cap29.34 Bn€
Total debt258.8 M€
Free Cash Flow241.7 M€
Debt / Equity9%
Profitability & ownership
ROE-12.8%
ROA3.1%
% insiders36.7%
% institutions27.7%
Last declaration on 10 April 2026
Declarations1 total
Executives●Sale14HKEX
€21,76516,071 shares@ €1.35430.0001% mcap100.0% of flow
ShareXHKG
HKEX:DA20260410E00415·
1 of 1 declaration